Trek Financial’s Novartis NVS Stock Holding History

Trek Financial’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$381K	Buy	2,496 +418	+20%	+$64.1K	0.02%	336
2025 Q4	$286K	Buy	+2,078	New	+$272K	0.02%	373

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trek Financial's NVS Position: Q1 2026 in Review

Trek Financial increased its Novartis (NVS) stake by 20% in Q1 2026, buying an estimated $64.1K and bringing the position to 2,496 shares worth $381K. The position accounts for 0.02% of the portfolio, ranked #336.

Trek Financial first reported a position in NVS in Q4 2025 and has held it in 2 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Trek Financial held 2,496 shares of Novartis worth $381K as of Q1 2026.
Trek Financial bought 418 Novartis shares in Q1 2026, an estimated $64.1K.
Novartis made up 0.02% of Trek Financial's portfolio in Q1 2026, its #336 holding.
Trek Financial first reported a position in Novartis in Q4 2025 and has held it in 2 quarters since.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Trek Financial's 13F filing for Q1 2026, filed 13 May 2026.